NEW YORK, Feb 6 – Informax's business strategy entails looking beyond off-the-shelf sales of its software toward developing hands-on collaborations, such as the partnership the company forged with Axcell Biosciences, Informax CEO Alex Titomirov said Tuesday.
“We’d like to have collaborations and technologies that map [bioinformatics] onto development,” Titomirov told GenomeWeb following a media seminar in New York.